Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
Neumora Therapeutics (Nasdaq: NMRA) will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026 at 10:15 a.m. ET.
Rhea-AI Summary
Neumora Therapeutics (Nasdaq: NMRA) will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026 at 10:15 a.m. ET. A live webcast will stream on the company's events and presentations page, with a replay archived for up to 30 days.
Positive
- None.
Negative
- None.
Details
News Market Reaction – NMRA
In the Apr 6 session, NMRA gained 6.00%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference date
- April 13, 2026
- Needham Virtual Healthcare Conference fireside chat
- Presentation time
- 10:15 a.m. ET
- Scheduled time for the Needham fireside chat
- Webcast archive period
- 30 days
- Replay availability on company website
Historical Context
-
Reported Q4 and 2025 results plus pipeline and cash runway update.
-
Announced timing and access details for Q4 and 2025 earnings call.
-
Planned fireside chat at Guggenheim Emerging Outlook: Biotech Summit 2026.
-
Outlined 2026 strategy, KOASTAL-2/3 expansion and NMRA-215 Phase 1 plans.
-
Reported positive NMRA-511 Phase 1b signal-seeking data in AD agitation.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WATERTOWN, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026 at 10:15 a.m. ET.
A live webcast of the fireside chat will be available on the events and presentations section of the Company’s website at www.neumoratx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Neumora
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the greatest medical challenges of our generation by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our therapeutic pipeline currently consists of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients.
Neumora Contact:
Helen Rubinstein
617-402-5700
Helen.Rubinstein@neumoratx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.